DLX6 and nasopharyngeal carcinoma: We analyzed the sequencing and clinical data of patients in Fujian Cancer Hospital and observed a significant elevation in DLX6 expression in nasopharyngeal tissues compared to para-cancerous tissues, which was the most obvious difference in expression between NPC and paracancerous tissues in the DLX family (Figures 1A–C).